While, our results of bioinformational analysis and preliminary experiments suggested that ataxin-1 and translationally-controlled tumor protein might be intermediate partner proteins between Na, K-ATPase and proteasome in HeLa cells treated with arenobufagin. The gene discussed is PROS1; the disease is neoplasm.